A phase II study evaluating the toxicity and efficacy of single-agent temsorilmus (TEM) in chemotherapy-naive castration-resistant prostate cancer (CRPC): First report of suggested activity.

From the Department of Surgery, Yale University and the New Haven Hospital, New Haven, Connecticut. Read at a combined meeting of the New York, Philadelphia and New England Branches of the American ...

Phase I/II study of hypofractionated intensity modulated radiotherapy (IMRT) for prostate cancer including simultaneously integrated boost (SIB). The 4Kscore to predict the grade and stage of prostate ...

Credit: Getty Images Investigators examined 5-year prostate cancer-specific mortality rates associated with 5 histologic subtypes, 4 of them rare. Compared with the dominant subtype, acinar ...

Microscopic glands of the prostate are segmented (colored) with the new deep-learning pipeline; the image shows a prostate cancer tissue volume, measuring roughly 1 x 1 x 2 mm in size. The prostate ...

Prostate cancer stands as a prevalent threat to men's health, ranking second in cancer-related deaths in the United States. Each year, approximately 250,000 men in the U.S. receive a prostate cancer ...